Dr. Gary Sibbald is the world-renowned dermatologist who is leading Rimon’s initial clinical trial for its MI-Sorb™ dressing, validating its unique Theramer™ technology. Dr. Sibbald is a co-founder of the Canadian Association of Wound Care (CAWC) and is on the editorial or advisory board of several wound care journals. Lecturing extensively, he is also a prolific author and an educator, sponsoring regular clinics to promote the interdisciplinary approach to wound healing.

Recently, I was given the opportunity to speak with Dr. Sibbald about wound care and the MI-Sorb™ clinical trial. The interview is available to download through the link provided below.

Dr. Michael Sefton is one of the pioneers of Tissue Engineering and is a co-founder of Rimon Therapeutics.  A Professor of Chemical Engineering and former Director of the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, Dr. Sefton is a leader at the University and in the wider scientific community. A few years ago he was awarded the prestigious title of University Professor by the University of Toronto and last year he was named a Fellow of the Royal Society of Canada.

Dr. Sefton sits on the editorial boards of several prominent journals and has been on the grant selection committees for NSERC, MRC (now CIHR) and the US NIH. Dr. Sefton is the author of over 140 peer reviewed journal articles and is the recipient of many awards. For a complete bio see: http://www.rimontherapeutics.com

We had an opportunity to speak with Micheal Sefton at the Rimon Therapeutics’s office in late May about his career, Rimon Therapeutics, and the Biomaterials Sector in Canada. Here is what we discussed:

Dr. Michael May and Professor Michael Sefton are the co-founders of Rimon. Professor Sefton is a pioneer of “tissue ...   more »